Author Topic: (Abst.) PML in Tecfidera-treated MS patients  (Read 45 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9419
  • MS diagnosed 1980
  • Location: Pacific Northwest
(Abst.) PML in Tecfidera-treated MS patients
« on: August 20, 2020, 10:33:11 am »
From PubMed (August 20, 2020)--"Progressive multifocal leucoencephalopathy in dimethyl fumarate-treated multiple sclerosis patients":


https://pubmed.ncbi.nlm.nih.gov/32808554/


The researchers are affiliated with the Consortium of Multiple Sclerosis Centers (CMSC) and the University of Michigan.
MS Speaks--online for 16 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

Offline agate

  • Administrator
  • *****
  • Posts: 9419
  • MS diagnosed 1980
  • Location: Pacific Northwest
PML outcomes in MS patients treated with dimethyl fumarate
« Reply #1 on: November 13, 2022, 09:41:08 pm »

Some Biogen researchers have published a report on MS patients being treated with dimethyl fumarate who developed PML.


From Multiple Sclerosis Journal (November 10, 2022)--"Progressive multifocal leucoencephalopathy outcomes in patients with multiple sclerosis treated with dimethyl fumarate":


https://journals.sagepub.com/doi/full/10.1177/20552173221132469
« Last Edit: November 13, 2022, 09:48:09 pm by agate »
MS Speaks--online for 16 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics